Background: Survivin, a novel member of the inhibitor of apoptosis family, plays an important role in cell cycle regulation. A common polymorphism at the survivin gene promoter (G/C at position 31) was shown to be correlated with survivin gene expression in cancer cell lines.
Aim: To investigate whether this polymorphism could be involved in the development of human papillomavirus (HPV)-associated cervical carcinoma.
Methods: Survivin promoter polymorphism was detected in patients with cervical cancer, in patients with equivocal cytological atypia and in a control population using polymerase chain reaction (PCR-restriction fragment length polymorphism (RFLP) and PCR-single strand conformation polymorphism analysis. HPV was typed in patients with cervical cancer and cytological atypia using PCR-RFLP.
Results: No statistically significant differences were found in the genotype distributions of the survivin promoter variants among our study groups.
Conclusions: The survivin promoter polymorphism at position 31 may not represent an increased risk for the development of cervical cancer, at least in the population studied here.
- ASC, atypical squamous cells
- CDE, cycle-dependent element
- CHR, cycle homology region
- HPV, human papillomavirus
- PCR, polymerase chain reaction
- RFLP, restriction fragment length polymorphism
- SSCP, single-strand conformation polymorphism
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Published Online First 19 May 2006
Funding: This study was supported by grants from the Hungarian Scientific Research Fund (OTKA T049191 and T046608).
Competing interests: None.